adult
outpati
ili
attend
emerg
room
univers
hospit
bueno
air
argentina
centro
de
e
investigacion
cemic
two
consecut
winter
includ
period
correspond
epidemiolog
week
respect
ill
defin
fever
least
last
hour
symptom
least
one
upper
respiratori
signsymptom
cough
nasal
discharg
throat
sore
least
one
follow
system
signsymptom
headach
myalgia
malais
chill
prostrat
patient
gather
inclus
criteria
invit
read
sign
inform
consent
accept
includ
studi
throat
nasal
swab
collect
emerg
room
sent
viral
transport
media
virolog
laboratori
clinic
data
includ
age
symptom
flu
vaccin
presenc
immunosupress
clinic
manag
end
visit
record
form
special
design
studi
attend
physician
emerg
room
decid
whether
patient
requir
symptomat
andor
antivir
antibiot
treatment
studi
approv
local
irb
sampl
process
iif
monoclon
antibodi
chemicon
temecula
ca
usa
flu
flu
b
parainfluenza
adenoviru
rsv
sampl
n
test
iif
hmpv
detect
addit
specimen
year
retrospect
cultur
flu
adenoviru
detect
inocul
mdck
cell
line
patient
posit
viral
result
iif
telephon
within
hour
princip
investig
evalu
complic
evalu
util
viral
treatment
suggest
infect
control
measur
complic
suspect
patient
reexamin
flu
posit
sampl
sent
nation
center
influenza
carlo
g
character
strain
test
student
use
analyz
continu
variabl
test
categor
one
relationship
variabl
evalu
use
spearman
correl
coeffici
pearson
correl
coeffici
categor
continu
variabl
respect
statist
signific
assum
p
valu
less
logist
regress
model
use
calcul
odd
ratio
respect
confid
interv
specimen
receiv
laboratori
adequ
cell
diagnosi
iif
year
sampl
flu
posit
flu
b
posit
iif
cell
cultur
allow
detect
three
flu
case
three
flu
b
case
one
adenoviru
case
tabl
sensit
iif
compar
cell
cultur
flu
year
circul
flu
detect
week
case
flu
b
observ
whole
studi
period
rsv
detect
flu
strain
subtyp
four
flu
isol
similar
vaccin
strain
four
antigen
differ
vaccin
viru
close
relat
rest
could
character
character
achiev
sampl
flu
flu
b
flu
strain
character
close
relat
vaccin
strain
flu
b
one
strain
similar
bhong
victoria
lineag
vaccin
strain
correspond
yamagata
lineag
vaccin
strain
southern
hemispher
mean
age
patient
year
sd
predominantli
femal
statist
differ
posit
neg
group
regard
sex
age
tabl
patient
receiv
annual
flu
vaccin
one
immunocompromis
patient
flu
posit
none
sign
symptom
significantli
associ
posit
neg
result
tabl
complic
report
none
patient
requir
hospit
one
flu
posit
patient
receiv
empir
oseltamivir
emerg
room
renal
transplant
immunosuppress
treatment
rest
patient
consult
averag
hour
symptom
start
addit
viral
diagnosi
ifi
alway
avail
day
oseltamivir
effect
within
hour
onset
symptom
could
implement
treatment
patient
inadequ
use
antibiot
observ
studi
two
flu
neg
patient
given
empir
antibiot
develop
bacteri
pneumonia
hospit
studi
young
adult
outpati
ili
viral
etiolog
correspond
flu
viru
follow
rsv
studi
shown
similar
even
lower
viral
detect
young
adult
studi
investig
common
respiratori
virus
routin
detect
convent
immunofluoresc
assay
monoclon
antibodi
cell
cultur
therefor
molecular
method
would
use
viral
detect
would
possibl
higher
concept
especi
true
virus
rsv
iif
recommend
diagnosi
adult
nevertheless
studi
signific
proport
patient
ili
remain
without
etiolog
diagnosi
lead
us
inevit
question
agent
caus
major
ili
adult
popul
virus
rhinoviru
enterovirus
new
coronaviru
bocaviru
could
implic
would
surpris
new
virus
caus
ili
discov
near
futur
moreov
applic
molecular
method
reveal
exist
coinfect
two
respiratori
virus
clinic
signific
find
yet
determin
correl
observ
specif
sign
symptom
etiolog
reinforc
need
rapid
viral
diagnosi
order
defin
etiolog
prevent
indiscrimin
use
antibiot
reduc
unnecessari
intervent
implement
measur
includ
isol
infect
individu
lina
valett
also
observ
viral
etiolog
patient
ili
diseas
predict
basi
clinic
pictur
flu
viru
respond
use
antivir
treatment
start
within
first
day
onset
fever
studi
patient
consult
hour
onset
symptom
addit
viral
diagnosi
ifi
avail
day
therefor
result
use
time
manner
antivir
treatment
rapid
antigen
devic
flu
give
result
within
hour
use
case
side
viral
etiolog
permit
infect
control
measur
like
patient
isol
particularli
import
popul
immunocompromis
patient
close
contact
addit
viral
etiolog
contribut
epidemiolog
data
permit
identif
circul
strain
flu
strain
patient
similar
correspond
vaccin
strain
southern
hemispher
correspond
year
diagnosi
specif
character
flu
strain
import
order
provid
earli
warn
potenti
flu
pandem
epidem
conclus
viral
diagnosi
achiev
almost
patient
ili
frequent
viru
flu
follow
flu
b
rsv
human
metapneumoviru
detect
case
similar
describ
previous
studi
repres
first
one
evalu
viral
etiolog
young
adult
outpati
ili
argentina
